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A thorough understanding of the dose–response relationship 
is required for optimizing the efficacy of anesthetics 
while minimizing adverse drug effects.1 Nowadays, except for 
the inhaled anesthetics (for which end-tidal concentrations 
can be measured online), most of the drugs used in clinical 
anesthesia are administered using standard dosing guidelines, 
without giving due consideration to their pharmacokinetics 
and dynamics in guiding their administration. Various 
studies have found that introducing pharmacokinetics 
and pharmacodynamics as part of the inputs in clinical 
anesthesiology could lead to better patient care.2 With this 
in mind, it is extremely important that clinicians understand 
and apply the principles of clinical pharmacology that 
determine the time course of a drug’s disposition and effect.
Clinical pharmacology is one of the most challenging topics 
to teach in anesthesiology. The development of simulators 
to illustrate the time course of a drug’s disposition and 
effect provides online visualization of pharmacokinetic–
pharmacodynamic information during the clinical use of 
anesthetics. The aim of this review is to discuss the importance 
of simulation as a clinical pharmacology teaching tool for 
trainees in anesthesiology.
Learning from simuLations
Basic knowledge of drug disposition and effect is an integral 
part of the clinical practice of anesthesiology. Unfortunately, 
the basic concepts of pharmacokinetics and pharmacodynam-
ics are not always easy to understand or to apply directly to 
clinical practice. It might be difficult to extrapolate data relating 
to absorption, distribution, and clearance and their changes 
over a period of time directly into clinical practice. Predicting 
the onset and offset of drug effect during drug administration 
might be challenging, given that the plasma is not the site of 
drug effect for most anesthetic drugs.3,4 Thanks to the avail-
ability of computer technology, this extended knowledge can 
be incorporated into simulation packages so that clinicians 
can simulate the time course of a drug’s disposition and effect 
while the drug is being administered and its effect is being 
measured. Computer simulations are frequently used in vari-
ous disciplines to evaluate control systems.5,6 After learning 
clinical pharmacology through simulations, anesthesiologists 
will be able to answer the following questions: What plasma 
and effect-site concentration do I get when I inject 1 mg/kg of 
propofol and how long does it take to see the onset and offset? 
Does it take longer to see the offset of drug effect when admin-
istering fentanyl for 5 min or 5 h? How are sevoflurane and 
remifentanil interacting? How does a target-controlled drug 
infusion (TCI) work?
incorporation of cLinicaLLy avaiLabLe 
 pharmacokinetic/pharmacodynamic tooLs
New methods of drug administration have been developed and 
are now used clinically. Drug effects are more easily measured 
using more accurate and more specific monitoring devices. The 
aim of these developments is to use principles from the phar-
macology of anesthetics to optimize drug titration, by better 
controlling the overall relationship between drug dose and the 
desired response. Various technologies are available in the oper-
ating room and can be used as online teaching tools.
For intravenously administered anesthetic drugs, includ-
ing propofol, opiates, and muscle relaxants, TCI systems are 
commercially available. TCI is an infusion controlled in such 
a manner as to achieve a user-defined estimated drug concen-
tration in a body compartment or tissue of interest. An anes-
thesiologist using a TCI system to administer an anesthetic 
agent is able to set and adjust a desired drug concentration, 
usually referred to as the “target concentration,” based on clini-
cal observation of the patient or measurement of drug effect. 
Multicompartmental pharmacokinetic models are used by TCI 
systems to calculate the infusion rates required for achiev-
ing the target concentration. A computer or microprocessor 
is required for performing the complex calculations and to 
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control the infusion pump. Classically, plasma- or effect-site 
concentrations are targeted.7
As shown in Figure 1, commercially available systems also 
provide online information of the predicted plasma- and effect-
site concentrations of the given drugs. This allows the clinician 
to learn more about the concentration–clinical effect relation-
ship while administering the drug. Commercial pumps can also 
be connected to personal computer software programs to pro-
vide online predictions of plasma- and effect-site concentrations. 
A good example of such a program is RUGLOOP (Demed, 
Temse, Belgium), developed by De Smet and Struys and available 
at http://www.demed.be. Various investigators are also studying 
the time course between measurable end-tidal concentrations of 
inhaled anesthetics and drug effects. Hysteresis data are avail-
able for various inhaled drugs and will be incorporated in future 
applications of this technology.8,9
Aside from displaying predicted effect-site concentrations for 
inhaled and intravenous drugs, the measuring of specific drug 
effects is one of the major achievements in anesthesiology and 
has to be considered as an integral part of pharmacology anes-
thetic. Although end points, such as hypnosis and analgesia, can 
be measured only in terms of surrogate indices, spontaneous and 
evoked electroencephalographic derived indices can be moni-
tored as real-time surrogate indices of hypnotic drug effect.10 
In an attempt to measure the balance between nociception and 
pharmacologically induced antinociception, various measures of 
the “status” of the autonomic nervous system during anesthesia 
have been studied, such as heart rate variability and the variability 
of the pulse plethysmography amplitude.11–14 It is already pos-
sible in clinical practice to combine dose–response information 
both from the concentration and the drug effect monitors, to 
guide the administration of hypnotic drugs, and there is evidence 
that the simultaneous use of these two clinical pharmacological 
sources of information offers improved patient care.15
Currently, achieving an optimal level of anesthesia requires the 
combined use of hypnotic and opiate drugs. An accurate level of 
the hypnotic component as well as an optimal level of the anal-
gesic component are required for anesthesia in patients who are 
to undergo surgery. The noxious stimulus should be identified 
properly and blocked at the spinal level. Classically, this is done 
by using opioids and/or locoregional anesthetic techniques. 
Recently, inhaled anesthetics have been shown to exert some of 
their effects at the level of the spinal cord and could offer an 
alternative method of blocking ascending stimuli from reaching 
the cerebral cortex, where they cause an arousal reaction.16–18 If 
an opioid is used along with a hypnotic drug, their interaction 
has to be considered. The most detailed study of this interaction 
uses response surface methods.19 The hypnotic–opiate balance 
has been described for intravenous drugs.20–23 Recently, Manyam 
et al.24 have studied the interaction between sevoflurane and 
remifentanil. Response surface pharmacodynamic interaction 
models were built using the pooled data for sedation and anal-
gesic end points. Apart from the hypnotic–opioid interaction, 
one has also to consider an interaction between two hypnotics. 
Classically, an induction bolus of one drug is given intravenously, 
followed by an inhaled drug for maintenance of hypnosis. It was 
found recently that the combined effect of propofol and sevo-
flurane on loss of consciousness and movement of the patient at 
the time of skin incision, during  general anesthesia, is additive 
and not synergistic.25
avaiLabiLity of simuLation programs
Simulation technology and pedagogy have advanced dramati-
cally in recent years and have the potential to improve the com-
petency of anesthesiologists and ensure a safer use of anesthetic 
drugs in practice.26 A wide range of simulation technology prod-
ucts is available for teaching the pharmacology of anesthetics, 
ranging from Excel spreadsheets through the new generation of 
computer-driven, screen-based, realistic, and virtual reality sim-
ulators. Various tools are available to simulate the time course 
of plasma- and/or effect-site concentrations when using one or 
more drugs. These packages also offer instruction in TCI.
Several early software simulation programs such as 
STANPUMP, STELPUMP, STANGRAPH, RUGLOOP I, and 
a
b
figure 1 Commercially available target-controlled infusion devices. 
(a) Shows the BASE PRIMEA system (Fresenius, Brézins, France), including 
two pumps and the target-controlled infusion controller with color display. 
(b) Shows the ASENA PK TCI pump (Cardinal Health Alaris Products, 
Basingstoke, UK). Both systems can control the predicted plasma and 
effect-site concentrations of the given drugs. The displays show the trend 
and prediction of the time course of drug concentrations. Reprinted with 
permission of the respective companies.
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IVA-SIM have been collected by Dr. Steven Shafer at Stanford 
University and are still available at http://anesthesia.stanford.
edu/pkpd/. Minto and Schnider developed a complete set of 
add-in tools for Excel (Microsoft Corporation, Redmond, 
WA). This software, called “PKPDTOOLS,” is available from 
http://www.pkpdtools.com/. These spreadsheet applications 
are becoming very popular for data handling in research and 
education and provide user-friendly tools covering all the basic 
situations commonly encountered in pharmacokinetic/pharma-
codynamic modelling. PKPDTOOLS has additional reparame-
terization functions, can simulate TCI, and has context-sensitive 
half-time functions. Additional dedicated pharmacokinetic/
pharmacodynamic simulations with Excel are available at http://
www.demed.be.
A user-friendly simulator is TIVATRAINER, developed by 
Dr. F. Engbers at Leiden University (available at http://www.
eurosiva.org) (Figure 2a). This simulation program is capa-
ble of showing the plasma- and effect-site concentrations of 
various intravenously administered anesthetics. There are 
various modes of administration, including manual, TCI, 
effect-site controlled infusion, as well as an intravenous-assist 
mode whereby the “ideal” manual input is calculated by the 
a
b
figure 2 Examples of personal computer–based simulation programs. 
The upper part shows a screenshot from TIVATRAINER software and the 
lower part shows a screenshot from GASMAN. Reprinted with permission of 
Dr. F. Engbers and Dr. J. Philip.
a
b
figure 3 Online advisory displays including characteristics of drug behavior 
and interaction. (a) The SmartPilot (Dräger, Lübeck, Germany). The two-
dimensional display shows the effect-site concentrations of combined 
drugs (opioids/intravenous hypnotics or inhalation anesthetics) based on 
pharmacokinetic models, and the resulting anesthesia effect based on 
pharmacodynamic models. Gray-shaded areas indicate different levels of 
anesthesia. The white point indicates the current combination of effect-site 
concentrations, the light gray line shows the retrospective concentrations, 
and the black point and arrow mark the 10- and 15-min predictions, 
respectively, already calculated at the time of presetting the delivery of the 
drug. Event markers may be set to show the specific states of the patient 
in relation to the level of anesthesia. The time-based real-time curves, 
trends, and prediction of effect-site concentrations of individual drugs, the 
resulting anesthesia effect (Noxious Stimulus Response Index) and correlated 
BIS, vital signs, and event markers as reference for interpretation. (b) The 
Medvis display (Medvis, Salt Lake City, UT) shows a real-time visualization 
of the pharmacology of anesthetic drugs, using pharmacokinetic and 
pharmacodynamic models to predict drug effect-site concentrations and 
drug effects in the past, current time, and 10 min into the future. Drug doses 
administered in the form of boluses and infusions are controlled through 
separate data interfaces or user interfaces. Drugs are categorized according 
to sedation (top plot), analgesia (middle plot), and muscle relaxation (bottom 
plot). Effects are depicted as a population-based probability of producing 
unconsciousness (top plot), no response to tracheal intubation (middle plot), 
and no twitch response to a train of four stimuli (bottom plot). In addition, 
a second pharmacodynamic end point, POST-OP ANALG, represents a 
guideline therapeutic window for postoperative pain. Synergistic interactions 
of sedative/hypnotics and analgesics are shown as white lines in the plot. 
For example, the top plot shows that, with the use of propofol alone, the 
probability of producing unconsciousness is between 50 and 95% (yellow 
line) but, because propofol interacts with the opioids, the probability of 
unconsciousness is >95% (white line). Similarly, propofol potentiates the 
effect of the opioids in the middle plot.
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making automated dosing decisions to reach and maintain a 
preset target.33 These systems might help the anesthesiologist 
to titrate drug administration without overshoot, to guide the 
monitoring of variables, and to optimize control of  physiological 
functions.
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program. Drug–drug interactions between opiates and hyp-
notics can be pictured using data from Vuyk et al.27 A per-
sonal computer screen–based solution for simulating the time 
course of the pharmacokinetics and dynamics of inhaled anes-
thetics is GASMAN (http://www.gasmanweb.com), developed 
by Dr. J. Philip at Harvard Medical School. Figure 2b shows 
the time course of the uptake of an anesthetic drug in critical 
body compartments—lungs, heart, and brain—as well as in the 
breathing circuit and vaporizer.
Several academic centers have developed simulation tools to 
aid the learning and better understanding of clinical pharmacol-
ogy. The University of Florida Department of Anesthesiology 
has developed the “Virtual Anesthesia Machine” website (http://
vam.anest.ufl.edu/), which offers teaching tools such as com-
partment PK models, pill dosage/compliance simulations, anes-
thesia machine simulation with inhaled anesthetics, and many 
others. The commercially available software BODY Simulation 
(Advanced Computer Simulations, Point Roberts, WA) simu-
lates human physiology and pharmacology, runs on standard 
personal computers, and is built around a collection of models 
of the cardiopulmonary system originally published by Fukui 
and Smith.28 In this program, a detailed user interface has been 
customized to represent the operating room environment. 
Aside from personal computer screen–based simulators, vari-
ous realistic high-end interactive patient simulators are avail-
able that use a full-size mannequin for full case–based training 
in anesthesiology.26
In the near future, all sources of pharmacological and effect 
monitoring will be combined into anesthetics advisory and 
feedback systems, expanding the existing kinetics-based tech-
nology available for administration of anesthetics so as to 
include total coverage of the dose–response relation. By mea-
suring the patient’s individual response to a given drug dose, 
drug administration could be guided by a pharmacodynamic 
advisory system that estimates the complete dose–response 
relation. Recently, various display systems have been developed 
and tested. Schumacher et al.29 proposed an advisory system 
that leaves the anesthesiologist in complete control of dosing 
but enables him to obtain real-time information about the pre-
dicted drug concentrations, predicted combined effect, and pre-
dicted wakeup time resulting from his actions. Simultaneously, 
the system displays, in an intuitively appealing format, the opti-
mal drug concentration ratio for a given effect in the typical 
patient. Albert et al.30 have developed a pharmacological dis-
play system that can be used online in the operation room for 
accurately modeling the concentration and effect of anesthetic 
drugs administered alone and in combinations. This enables 
the anesthesiologist to visualize the sedation, analgesia, and 
muscle relaxation status of a patient on the basis of general 
population models that have been corrected for body mass, age, 
and sex. Thereby, it gives the anesthesiologist the ultimate tool 
to fully integrate clinical pharmacology into daily practice so 
as to achieve better patient care.31,32 A commercially available 
system is shown in Figure 3.
Ultimately, when technology is considered to have become 
mature enough, closed-loop technology could be used for 
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